Viatris VTRS
NASDAQ VTRS
$16.44 -0.17 (-0.99%)
As of: Sep 9, 2026 · 3:06 PM EDT

Viatris (VTRS) Non-Current Debt (2019 - 2026)

Viatris (VTRS) posted Non-Current Debt of $11.6 billion for Q2 2026, down 6.45% on a QoQ basis from $12.4 billion in Q1 2026, and down 9.22% year-over-year from $12.8 billion in Q2 2025.

Analysis

Viatris (VTRS) Non-Current Debt (2019 - 2026) Analysis & Trends

Viatris has reported Non-Current Debt for 8 years, with the latest figure at $11.6 billion in Q2 2026.

  • On a quarterly basis, Non-Current Debt fell 9.22% year-over-year to $11.6 billion in Q2 2026; TTM through Jun 2026 was $11.6 billion, a 9.22% decrease from a year earlier, with the FY2025 full-year figure at $12.5 billion, down 11.1% from the prior year.
  • Non-Current Debt was $11.6 billion for Q2 2026 at Viatris, down from $12.4 billion in the prior quarter.
  • The five-year high for Non-Current Debt was $19.2 billion in Q2 2022, with the low at $11.6 billion in Q2 2026.
  • Average Non-Current Debt over 5 years is $15.5 billion, with a median of $15.4 billion recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Debt declined 3.69% in 2023, then retreated 16.24% in 2024.
  • Over 5 years, Non-Current Debt stood at $18.0 billion in 2022, then retreated by 10.14% to $16.2 billion in 2023, then declined by 13.28% to $14.0 billion in 2024, then fell by 11.1% to $12.5 billion in 2025, then decreased by 6.96% to $11.6 billion in 2026.
  • The last three Non-Current Debt figures came in at $11.6 billion (Q2 2026), $12.4 billion (Q1 2026), and $12.5 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Teva Pharmaceutical Industries 42.53 Bn 38.88 Bn 2.15 Bn 12.09 Bn
2 Viatris 19.14 Bn 18.25 Bn 1.46 Bn 11.61 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 150.67 Mn
4 Amneal Pharmaceuticals 5.45 Bn 5.33 Bn 334.51 Mn 2.57 Bn
5 Bausch Health Companies 2.33 Bn 492.63 Mn 2.10 Bn 20.74 Bn
6 Alvotech 1.51 Bn 1.36 Bn 2.56 Mn 1.26 Bn
7 Ani Pharmaceuticals 1.48 Bn 1.12 Bn 165.89 Mn 280.16 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 609.56 Mn
9 Fennec Pharmaceuticals 400.20 Mn 358.95 Mn 17.15 Mn -
10 RedHill Biopharma 178.79 Mn 178.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.61 Bn
Mar 31, 2026 12.41 Bn
Dec 31, 2025 12.48 Bn
Sep 30, 2025 12.49 Bn
Jun 30, 2025 12.79 Bn
Mar 31, 2025 14.18 Bn
Dec 31, 2024 14.04 Bn
Sep 30, 2024 14.30 Bn
Jun 30, 2024 14.73 Bn
Mar 31, 2024 16.07 Bn
Dec 31, 2023 16.19 Bn
Sep 30, 2023 17.08 Bn
Jun 30, 2023 17.25 Bn
Mar 31, 2023 18.07 Bn
Dec 31, 2022 18.02 Bn
Sep 30, 2022 18.72 Bn
Jun 30, 2022 19.21 Bn
Mar 31, 2022 18.76 Bn
Dec 31, 2021 19.72 Bn
Sep 30, 2021 19.85 Bn